Here is What to Know Beyond Why Oscar Health, Inc. (OSCR) is a Trending Stock

Core Viewpoint - Oscar Health, Inc. (OSCR) has experienced a stock return of -8.5% over the past month, contrasting with the Zacks S&P 500 composite's +0.6% change, indicating potential challenges ahead for the stock [1] Earnings Estimates - Oscar Health is projected to post earnings of $1.21 per share for the current quarter, reflecting a year-over-year increase of +31.5%, with a significant upward revision of +43.2% in the Zacks Consensus Estimate over the last 30 days [4] - For the current fiscal year, the consensus earnings estimate of $0.2 indicates a remarkable change of +111.8% from the previous year, with a substantial revision of +168.5% in the last month [4] - The consensus earnings estimate for the next fiscal year stands at $1.06, suggesting a change of +430% compared to the prior year, with no changes in the estimate over the past month [5] Revenue Growth - The consensus sales estimate for the current quarter is $4.89 billion, indicating a year-over-year growth of +60.6%, while estimates for the current and next fiscal years are $18.91 billion and $21.16 billion, reflecting increases of +61.6% and +11.9%, respectively [10] Recent Performance and Surprise History - In the last reported quarter, Oscar Health generated revenues of $2.81 billion, marking a year-over-year increase of +17.3%, but reported an EPS of -$1.24, which is a decline from -$0.62 a year ago [11] - The company reported revenues that were -12.49% below the Zacks Consensus Estimate of $3.21 billion, and the EPS surprise was -47.62% [11] - Over the last four quarters, Oscar Health has surpassed consensus EPS estimates three times but only exceeded revenue estimates once [12] Valuation - Oscar Health is graded B in the Zacks Value Style Score, indicating that it is trading at a discount compared to its peers, which suggests potential undervaluation [16]